Dolby's Revenue Climbs 6.3% to $1.35B, Boosts Dividend 9%

Ticker: DLB · Form: DEF 14A · Filed: Dec 16, 2025 · CIK: 1308547

Sentiment: mixed

Topics: Proxy Statement, Executive Compensation, Dividend Increase, Financial Performance, Corporate Governance, Virtual Meeting, Audit Firm Ratification

Related Tickers: DLB, ^MID

TL;DR

**DLB's revenue growth and dividend hike are bullish signals, but watch that GAAP net income dip – non-GAAP is doing the heavy lifting.**

AI Summary

Dolby Laboratories, Inc. (DLB) reported total revenue of $1.35 billion for fiscal 2025, a 6.3% increase from $1.27 billion in fiscal 2024. Despite this revenue growth, GAAP net income decreased by 2.6% to $255.0 million from $261.8 million in the prior year. However, non-GAAP net income saw a significant rise of 12.1% to $413.5 million, up from $369.0 million in fiscal 2024. Diluted earnings per share also declined by 2.6% to $2.62, while non-GAAP diluted earnings per share increased by 11.9% to $4.24. The company announced a 9% increase in its dividend, raising it from $0.33 to $0.36 per share in November 2025. Executive compensation for fiscal 2025 included annual incentive compensation payments at 94% of targets, based on achieving non-GAAP operating income of $447.5 million against a gate of $337.5 million and revenue of $1,349.1 million against a target of $1,365.0 million. Performance stock unit awards granted in fiscal 2022 vested at 70.37% of target due to an annualized relative total stockholder return of -9.88% against the S&P Midcap 400 Index.

Why It Matters

Dolby's revenue growth to $1.35 billion signals continued demand for its audio and imaging technologies, which is crucial for investors looking for top-line expansion in a competitive tech landscape. The 9% dividend increase to $0.36 per share directly benefits shareholders, demonstrating management's confidence and commitment to returning capital, potentially attracting income-focused investors. The decline in GAAP net income, despite non-GAAP growth, warrants investor scrutiny into underlying operational efficiencies and non-recurring items. For employees, the executive compensation structure, tied to revenue and non-GAAP operating income, aligns incentives with company performance, while customers benefit from ongoing innovation in Dolby's core technologies.

Risk Assessment

Risk Level: medium — The 2.6% decrease in GAAP net income to $255.0 million, despite a 6.3% increase in total revenue, indicates potential underlying cost pressures or non-operating factors impacting profitability. Additionally, the -9.88% annualized TSR relative to the S&P Midcap 400 Index for performance stock units vesting in fiscal 2025 suggests underperformance against a key benchmark, which could concern long-term investors.

Analyst Insight

Investors should scrutinize the reconciliation of GAAP to non-GAAP financial measures in Appendix A to understand the drivers behind the GAAP net income decline. Given the dividend increase and revenue growth, consider holding DLB for its income potential and market position, but monitor future GAAP profitability closely.

Financial Highlights

revenue
$1.35 billion
net Income
$255.0 million
eps
$2.62
revenue Growth
+6.3%

Executive Compensation

NameTitleTotal Compensation
Kevin YeamanPresident and CEO

Key Numbers

Key Players & Entities

FAQ

What were Dolby Laboratories' key financial results for fiscal 2025?

For fiscal 2025, Dolby Laboratories reported total revenue of $1.35 billion, a 6.3% increase from fiscal 2024. GAAP net income was $255.0 million, a 2.6% decrease, while non-GAAP net income rose 12.1% to $413.5 million.

How did Dolby Laboratories' executive compensation perform in fiscal 2025?

Named Executive Officers (NEOs) received annual incentive compensation payments at 94% of their targets for fiscal 2025. This was based on achieving non-GAAP operating income of $447.5 million and revenue of $1,349.1 million, against a target of $1,365.0 million.

What is the risk associated with Dolby Laboratories' financial performance in fiscal 2025?

The primary risk is the 2.6% decline in GAAP net income to $255.0 million, despite revenue growth. This suggests potential underlying issues affecting profitability, which is further highlighted by the -9.88% annualized relative TSR for performance stock units.

What is the dividend policy for Dolby Laboratories in fiscal 2025?

In November 2025, Dolby Laboratories announced a 9% increase in its dividend, raising it from $0.33 to $0.36 per share. This reflects a commitment to returning capital to stockholders.

Who are the key executive officers at Dolby Laboratories?

The key executive officers for fiscal 2025 include Kevin Yeaman (President and CEO), Robert Park (SVP and CFO), Andy Sherman (EVP, General Counsel, Corporate Secretary), John Couling (SVP, Entertainment), and Shriram Revankar (SVP, Advanced Technology Group).

What is the purpose of the Dolby Laboratories Annual Meeting of Stockholders on February 3, 2026?

The Annual Meeting on February 3, 2026, will address the election of eight directors, an advisory vote on Named Executive Officer compensation, and the ratification of KPMG LLP as the independent registered public accounting firm for fiscal year ending September 25, 2026.

How can Dolby Laboratories stockholders attend and vote at the Annual Meeting?

Stockholders can attend the Annual Meeting virtually via live webcast at meetnow.global/MGF9HHY on Tuesday, February 3, 2026, at 10:30 a.m. Pacific Standard Time. They can vote over the internet, by telephone, or by mailing a proxy card in advance.

What are Dolby Laboratories' executive stock ownership guidelines?

Dolby's executive stock ownership guidelines require the CEO to hold qualifying equity equal to five times their annual base salary, and other NEOs to hold two times their annual base salary. All NEOs were in compliance as of the end of fiscal 2025.

What firm has been appointed as Dolby Laboratories' independent registered public accounting firm for fiscal 2026?

KPMG LLP has been appointed by Dolby Laboratories' Audit Committee as the independent registered public accounting firm for the fiscal year ending September 25, 2026. Stockholders are being asked to ratify this selection.

How did Dolby Laboratories' stock price perform at fiscal year-end 2025?

Dolby Laboratories' stock price per share as of fiscal year-end 2025 was $72.39, representing a 4.3% decrease from the fiscal year-end 2024 price of $75.61. The high and low for fiscal 2025 were $89.66 and $68.24, respectively.

Industry Context

Dolby Laboratories operates in the audio, video, and broadcast technology sectors, providing solutions that enhance entertainment experiences. The industry is characterized by rapid technological advancements, increasing demand for high-quality audio and visual content across various platforms (streaming, gaming, cinema), and evolving consumer expectations for immersive experiences. Competition comes from both established technology players and emerging innovators in audio codecs, spatial audio, and video processing.

Regulatory Implications

As a technology company, Dolby is subject to various regulations including intellectual property laws, data privacy (e.g., GDPR, CCPA), and potentially antitrust scrutiny if its market dominance in certain audio technologies is perceived as anti-competitive. Compliance with these regulations is crucial to avoid fines and maintain market access.

What Investors Should Do

  1. Review the reconciliation of Non-GAAP to GAAP financial measures.
  2. Analyze the performance metrics tied to executive compensation.
  3. Monitor the company's stock price performance relative to benchmarks.

Key Dates

Glossary

Non-GAAP Net Income
Net income that excludes certain items that are not indicative of ongoing operating performance, such as stock-based compensation expenses or acquisition-related costs. (Provides a measure of profitability that management believes better reflects the company's core operational performance, showing a 12.1% increase to $413.5 million in fiscal 2025.)
Non-GAAP Diluted Earnings Per Share
Diluted earnings per share adjusted to exclude certain non-recurring or non-operational items. (Offers an alternative view of earnings per share, highlighting a significant 11.9% increase to $4.24 in fiscal 2025, contrasting with the GAAP EPS decline.)
Annual Incentive Compensation
Short-term cash bonuses paid to executives based on the achievement of specific performance goals. (For fiscal 2025, payments were at 94% of targets, indicating that while revenue and operating income targets were largely met, they fell slightly short of the maximum potential payout.)
Performance Stock Unit (PSU)
Stock awards granted to executives where the vesting and/or payout is contingent upon the achievement of specific performance metrics over a defined period. (PSUs granted in fiscal 2022 vested at 70.37% due to underperformance relative to the S&P Midcap 400 Index, reflecting a negative total stockholder return.)
Total Stockholder Return (TSR)
A measure of the total return an investor receives from owning a stock, including stock price appreciation and dividends. (The annualized relative TSR of -9.88% against the S&P Midcap 400 Index for fiscal 2022 PSU grants directly impacted executive compensation outcomes.)

Year-Over-Year Comparison

Dolby Laboratories reported a 6.3% increase in total revenue to $1.35 billion for fiscal 2025, a positive trend from the prior year. However, GAAP net income saw a slight decrease of 2.6% to $255.0 million, while Non-GAAP net income grew by a more robust 12.1% to $413.5 million, indicating that adjustments for certain items significantly boosted reported profitability. Diluted EPS followed the GAAP net income trend with a 2.6% decline, whereas Non-GAAP diluted EPS rose 11.9%. The company also increased its quarterly dividend by 9% to $0.36 per share. Executive compensation was impacted by performance metrics, with annual incentives at 94% of target and a lower vesting rate for certain stock awards due to relative stock performance.

Filing Stats: 4,555 words · 18 min read · ~15 pages · Grade level 12.3 · Accepted 2025-12-16 08:30:55

Key Financial Figures

Filing Documents

Executive Compensation Tables and Related Matters

Executive Compensation Tables and Related Matters 55 Proposal 2 — Advisory Vote to Approve Named Executive Officer Compensation 72 Report of the Audit Committee of the Board of Directors 73 Proposal 3 — Ratification of Independent Registered Public Accounting Firm 74

Security Ownership of Certain Beneficial Owners and Management

Security Ownership of Certain Beneficial Owners and Management 76 Additional Meeting Matters 80 Delinquent Section 16(a) Reports 84 2025 Annual Report 85 Appendix A—Reconciliation of Non-GAAP to GAAP Financial Measures A-1 Table of Contents Proxy Statement Summary This summary highlights certain information contained elsewhere in this Proxy Statement. You should read the entire Proxy Statement carefully before voting as this summary does not contain all the information that you should consider. 2026 Annual Meeting of Stockholders The Annual Meeting will be held virtually via live webcast. Stockholders will not be able to attend the Annual Meeting in person. Tuesday, February 3, 2026 at 10:30 a.m. Pacific Standard Time Live webcast accessible at meetnow.global/MGF9HHY. Please see " Attending the Virtual Annual Meeting " beginning on page 81 for information on how to attend, submit questions and vote at the Annual Meeting. December 5, 2025 2026 PROXY STATEMENT| 1 Table of Contents Director Nominees The nominees for election to our Board at the 2026 Annual Meeting are listed below, along with their current committee assignments and certain biographical information about them as of December 5, 2025, the record date for the Annual Meeting. Committee Memberships Name and Position Independent Age Director Since AC CC NGC SPC TSC Kevin Yeaman President and CEO 59 2009 Peter Gotcher Chair of the Board 66 2003 David Dolby CEO, Dolby Family Ventures 48 2011 Tony Prophet Director 66 2021 Emily Rollins Director 55 2021 Simon Segars Director 58 2015 Anjali Sud CEO, Tubi, Inc. 42 2019 Avadis Tevanian, Jr Managing Director, NextEquity Partners 64 2009 AC Audit Committee CC Compensation Committee NGC Nominating and Governance Committee SPC Stock Plan Committee TSC Technology Strategy Committee Member Chair 2 |2026 PROXY STATEMENT Table of Contents Fiscal 2025 Fin

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on Read The Filing